Annual Report

Overview

The report presents the company's 2023 ESG performance across its pharmaceutical and fitness businesses. It highlights electricity-related emissions and resource-use disclosures, including water consumption and energy-saving initiatives such as solar generation and LED upgrades. The report also details a 709-person ESG reporting workforce, employee training, supply-chain controls and anti-corruption measures. It states that the Group recorded zero work-related fatalities during the year and that the Board oversees ESG policies and performance.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 28 March 2024
Language: English, Chinese
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services